Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-28 | 2026-09-28 | CTT PHARMACEUTICAL HOLDINGS, INC. | Director & CEO | Purchase | 3,400 | $0.06 | $187.00 | 9.43M | View | |
| 2026-09-22 | 2026-09-22 | CTT PHARMACEUTICAL HOLDINGS, INC. | Director & CEO | Purchase | 10.1K | $0.04 | $454.50 | 1.06M | View | |
| 2026-09-16 | 2026-09-16 | CTT PHARMACEUTICAL HOLDINGS, INC. | Director & CEO | Purchase | 10.9K | $0.05 | $523.20 | 9.41M | View | |
| 2026-09-10 | 2026-09-10 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 3,500 | $0.05 | $175.00 | 9.40M | View | |
| 2026-09-04 | 2026-09-04 | CTT PHARMACEUTICAL HOLDINGS, INC. | CEO | Purchase | 9,800 | $0.05 | $479.22 | 9.40M | View |
Informational purposes only, not investment advice.
tormere.com/research/CTTH · generated 2026-10-05
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-28 | CTT PHARMACEUTICAL HOLDINGS, INC. | P | 3,400 | $187 |
| 2026-09-22 | CTT PHARMACEUTICAL HOLDINGS, INC. | P | 10,100 | $454.5 |
| 2026-09-16 | CTT PHARMACEUTICAL HOLDINGS, INC. | P | 10,900 | $523.2 |
| 2026-09-10 | CTT PHARMACEUTICAL HOLDINGS, INC. | P | 3,500 | $175 |
| 2026-09-04 | CTT PHARMACEUTICAL HOLDINGS, INC. | P | 9,800 | $479.22 |
Tormere — informational purposes only, not investment advice.